By: Dana Weinstein, PharmD Candidate c/o 2022              Mycobacterium avium complex (MAC) infection in humans is caused by two main species, Mycobacterium avium and Mycobacterium intracellulare. These species are difficult to differentiate and therefore are collectively referred to as Mycobacterium avium-intracellulare (MAI).1 These acid-fast, atypical nontuberculosis mycobacterium (NTM) are the most common cause of lung disease in the U.S.2 MAC is…

By: Jason Ifeanyi, PharmD Candidate c/o 2022 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral strain responsible for causing COVID-19, continues to have a profound impact on communities at a local, national and global level. As of August 20, 2020, nearly 5.7 million confirmed cases exist in the United States with a total of…

By: William Obilisundar, PharmD Candidate c/o 2023, Binghamton University School of Pharmacy and Pharmaceutical Sciences              One of the most interesting events hosted by the Binghamton University School of Pharmacy during the 2019-2020 academic year was a seminar entitled, “Mental Health Awareness: A Focus on Suicide & Stigma,” presented by Dr. Carolyn M. Tyler, Ph.D.,…

By: Lyana Sayilar, PharmD Candidate c/o 2020 Approved on April 17, 2020, tucatinib (TukysaTM) is indicated to aid in the treatment of human epidermal growth factor receptor 2 (HER2) positive metastatic breast cancer and could be a potential add-on therapy.3 Among the different types of breast cancers, an increase of HER2, a transmembrane glycoprotein consisting…

By: Nishanth Viswanath, PharmD Candidate c/o 2022 Introduction   Chronic lymphocytic leukemia (CLL)  is a hematological malignancy of mature CD5 positive B-lymphocytes that primarily affects elderly patients.1 With the average age of diagnosis being 71, the incidence of CLL is relatively rare in younger populations, though cases have occurred in those under the age of 50.1…